SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...
The partnership pairs Pillar's portfolio of oncoReveal (R) kitted NGS panels with CellCarta's global laboratory network and biomarker expertise to reduce screening friction, improve turnaround time, ...
Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The Genome Partnership—the nonprofit organization that has organized the ...
Next-generation sequencing (NGS), especially long-read DNA sequencing, is transforming infectious organism detection by ...
Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...
This application note explores an automated electrophoresis system that enables objective DNA quality assessment from large ...
The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...
Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results